# Evaluate the Effectiveness and Safety of the Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulation on Fatigue, Mental Acuity, and Cognitive Health

> **NCT05170113** · NA · COMPLETED · sponsor: **Supplement Formulators, Inc.** · enrollment: 79 (actual)

## Conditions studied

- Fatigue

## Interventions

- **DIETARY_SUPPLEMENT:** Alpinia galanga formulation
- **DIETARY_SUPPLEMENT:** Theacrine formulation
- **DIETARY_SUPPLEMENT:** Caffeine formulation
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05170113
- **Lead sponsor:** Supplement Formulators, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-02
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2022-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05170113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05170113, "Evaluate the Effectiveness and Safety of the Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulation on Fatigue, Mental Acuity, and Cognitive Health". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05170113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*